Adjusted EBITDA rose to $31.9 million with a margin of 31%, up from $26.3 million in the prior year quarter.
Certara reported second quarter 2025 revenue of $104.6 million, a 12% year-over-year increase on a reported basis and 10% on a constant currency basis.
Diluted loss per share improved to $0.01 from a loss of $0.08, with adjusted diluted EPS steady at $0.07.
Net loss narrowed to $2 million from $12.6 million in the prior year quarter, while adjusted net income was $11.6 million, slightly up from $11.4 million.
Services revenue increased 5% to $57.9 million, supported by strong bookings growth in QSP and Simcyp services.
Software revenue grew 22% to $46.7 million, driven by strong growth from Simcyp and a $5.1 million contribution from Chemaxon.
Total bookings for the quarter were $112 million, up 13% year-over-year, with trailing 12-month bookings reaching $470.8 million, a 15% increase.
ACM Research reported Q2 2025 revenue of $215.4 million, up 6.4% year-over-year and 25% sequentially.
Cash and equivalents totaled $483.9 million, with net cash at $205.8 million.
Cash flow from operations was negative $39.6 million for the first half of 2025, with capital expenditures expected to be $70 million for the full year.
Gross margin was 48.7%, exceeding the target range of 42% to 48%.
Inventory increased to $648.3 million, driven by strategic raw material purchases to mitigate supply chain risks.
Net income was $36.8 million, slightly down from $37.5 million in Q2 2024, with net income per diluted share at $0.54.
Operating expenses increased 38.8%, with R&D at 14.5% of sales, sales and marketing at 9.3%, and G&A at 5.6%.
Operating income declined 20.2% to $41.5 million, with operating margin at 19.3% versus 25.6% in the prior year.
Shipments were $206 million, up 2% year-over-year and 32% sequentially, marking a return to positive shipment growth.
Entered a new $150 million revolving credit facility to enhance financial flexibility.
Free cash flow was negative $47.1 million due to $55 million purchase of the Farmers Branch facility and higher CapEx of $66.3 million.
GAAP net income was $9.1 million or $0.12 per share; non-GAAP net income was $21.2 million or $0.27 per share.
GAAP operating income was $12.3 million, up from $3.3 million in Q1; non-GAAP operating income was $22.8 million, up 35.2% from Q1.
Non-GAAP gross margin was 38.5%, at the low end of the range and 0.7 percentage points lower than Q1, mainly due to lower Systems segment margins and ramp-up costs for an HBM DRAM customer.
Probe Cards segment revenues were $162.1 million, up 18.7% sequentially, driven by foundry, logic, and DRAM markets.
Q2 revenues were $195.8 million, $0.8 million above the high end of the outlook range, with a 14.3% sequential increase and a 0.8% year-over-year decrease.
Systems segment revenues were $33.7 million, down $1.1 million sequentially, comprising 17.2% of total revenues.
Total cash and investments were $253 million, down $50 million from Q1.
Gen reported Q1 fiscal 2026 revenue of $1.26 billion, up 30% year-over-year on a reported basis and 10% on a pro forma basis excluding MoneyLion and an extra fiscal week.
Gen repurchased nearly 5 million shares and paid down $180 million in debt during the quarter.
Non-GAAP EPS was $0.64, up 20% year-over-year, exceeding the high end of guidance.
Non-GAAP operating margin was robust at 52%, with Cyber Safety Platform segment margin at 61% and Trust-Based Solutions segment margin at 31%.
Operating cash flow was $409 million and free cash flow was $405 million, up 55% year-over-year.
The company ended Q1 with $828 million in cash and over $2.3 billion in total liquidity including revolver.
Dafinchi